Table 2.

Recommendation regarding the use of Lp(a) measurements in clinical practice.

Guidelines	Recommendation
ESC/EAS (European Society of Cardiology/European Atherosclerosis Society) for the management of dyslipidemias [76]	Family history of premature cardiovascular disease Once in the lifetime of each adult person Moderate to high risk of cardiovascular event
HEART UK (Hyperlipidaemia Education and Atherosclerosis Research Trust UK) [77]	Calcific aortic valve stenosis Familial hypercholesterolaemia or other genetic forms of dyslipidaemia First-degree relatives of those with high Lp(a) levels (>200 nmol/L) Personal or family history of premature ASCVD (<60 years of age) A borderline increased 10-year risk of cardiovascular events
AHA/ACC (American Heart Association/American College of Cardiology) Guideline of the Management of Blood Cholesterol [78]	Personal or family history of premature ASCVD
NLA (National Lipid Association) [79]	Premature ASCVD Recurrent or progressive ASCVD
CCS (Canadian Cardiovascular Society) [80]	Family history of premature coronary artery disease Individuals with intermediate risk scores

ASCVD, atherosclerotic cardiovascular disease; Lp(a), lipoprotein (a).